Last updated on June 2016
A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers
Brief description of study
A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination with Nivolumab in Select Advanced Cancers
Detailed Study Description
The purpose of this study is to assess the safety, tolerability, and efficacy when combining INCB024360 and Nivolumab in subjects with certain cancers. This study will be conducted in 2 phases, Phase 1 (closed) and Phase 2 (open to enrollment)
Clinical Study Identifier: TX143886
Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )
